A prospective, randomized, controlled, open, multi-center phase II clinical study designed to evaluate the effectiveness and safety of teriprizumab injection combined with thermal ablation in the treatment of advanced liver cancer that has failed at least first-line treatment
Latest Information Update: 01 Dec 2020
At a glance
- Drugs Toripalimab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Dec 2020 New trial record